Show simple item record

dc.contributor.authorPiazzi, M
dc.contributor.authorWilliamson, Andrew J K
dc.contributor.authorLee, Chia-Fang
dc.contributor.authorPearson, Stella
dc.contributor.authorLacaud, Georges
dc.contributor.authorKouskoff, Valerie
dc.contributor.authorMcCubrey, James A
dc.contributor.authorCocco, L
dc.contributor.authorWhetton, Anthony D
dc.date.accessioned2015-05-26T08:48:07Zen
dc.date.available2015-05-26T08:48:07Zen
dc.date.issued2015-03-26en
dc.identifier.citationQuantitative phosphoproteome analysis of embryonic stem cell differentiation toward blood. 2015: Oncotargeten
dc.identifier.issn1949-2553en
dc.identifier.pmid25890499en
dc.identifier.urihttp://hdl.handle.net/10541/555805en
dc.description.abstractMurine embryonic stem (ES) cells can differentiate in vitro into three germ layers (endodermic, mesodermic, ectodermic). Studies on the differentiation of these cells to specific early differentiation stages has been aided by an ES cell line carrying the Green Fluorescent Protein (GFP) targeted to the Brachyury (Bry) locus which marks mesoderm commitment. Furthermore, expression of the Vascular Endothelial Growth Factor receptor 2 (Flk1) along with Bry defines hemangioblast commitment. Isobaric-tag for relative and absolute quantification (iTRAQTM) and phosphopeptide enrichment coupled to liquid chromatography separation and mass spectrometry allow the study of phosphorylation changes occurring at different stages of ES cell development using Bry and Flk1 expression respectively. We identified and relatively quantified 37 phosphoentities which are modulated during mesoderm-induced ES cells differentiation, comparing epiblast-like, early mesoderm and hemangioblast-enriched cells. Among the proteins differentially phosphorylated toward mesoderm differentiation were: the epigenetic regulator Dnmt3b, the protein kinase GSK3b, the chromatin remodeling factor Smarcc1, the transcription factor Utf1; as well as protein specifically related to stem cell differentiation, as Eomes, Hmga2, Ints1 and Rif1. As most key factors regulating early hematopoietic development have also been implicated in various types of leukemia, understanding the post-translational modifications driving their regulation during normal development could result in a better comprehension of their roles during abnormal hematopoiesis in leukemia.
dc.languageENGen
dc.language.isoenen
dc.rightsArchived with thanks to Oncotargeten
dc.titleQuantitative phosphoproteome analysis of embryonic stem cell differentiation toward blood.en
dc.typeArticleen
dc.contributor.departmentCell Signaling Laboratory, Department of Biomedical Science (DIBINEM), University of Bologna, Italyen
dc.identifier.journalOncotargeten
html.description.abstractMurine embryonic stem (ES) cells can differentiate in vitro into three germ layers (endodermic, mesodermic, ectodermic). Studies on the differentiation of these cells to specific early differentiation stages has been aided by an ES cell line carrying the Green Fluorescent Protein (GFP) targeted to the Brachyury (Bry) locus which marks mesoderm commitment. Furthermore, expression of the Vascular Endothelial Growth Factor receptor 2 (Flk1) along with Bry defines hemangioblast commitment. Isobaric-tag for relative and absolute quantification (iTRAQTM) and phosphopeptide enrichment coupled to liquid chromatography separation and mass spectrometry allow the study of phosphorylation changes occurring at different stages of ES cell development using Bry and Flk1 expression respectively. We identified and relatively quantified 37 phosphoentities which are modulated during mesoderm-induced ES cells differentiation, comparing epiblast-like, early mesoderm and hemangioblast-enriched cells. Among the proteins differentially phosphorylated toward mesoderm differentiation were: the epigenetic regulator Dnmt3b, the protein kinase GSK3b, the chromatin remodeling factor Smarcc1, the transcription factor Utf1; as well as protein specifically related to stem cell differentiation, as Eomes, Hmga2, Ints1 and Rif1. As most key factors regulating early hematopoietic development have also been implicated in various types of leukemia, understanding the post-translational modifications driving their regulation during normal development could result in a better comprehension of their roles during abnormal hematopoiesis in leukemia.


This item appears in the following Collection(s)

Show simple item record